Inductive Bio
PrivateLast Round
Grant
Dec 8, 2025
Total Funding Raised
$29.3M
Momentum Score
25 /100
Company Overview
Inductive Bio is a technology company that has developed a collaborative AI and machine learning (ML) platform to accelerate small molecule drug discovery. The company's primary focus is on solving challenges related to absorption, distribution, metabolism, excretion, and toxicity (ADMET). By creating a pre-competitive data consortium, Inductive Bio enables multiple companies to contribute anonymized data in a secure environment, building a foundational dataset for its AI models. This approach powers their "Compass" platform, which predicts a drug's ADMET properties before synthesis, guiding chemists toward molecules with a higher probability of success. The company aims to democratize access to its technology across the industry and has long-term plans to launch an AI-native contract research organization (CRO).
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, ML Platforms, Medical AI, Biotechnology
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inductive Bio Comps
Public and private peers based on sector, stage, and business model.
Inductive Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 8, 2025 | ||||
| Series A | May 7, 2025 | ||||
| Seed | Dec 13, 2023 |
Inductive Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series A, Seed |
| S32 | Series A |
| AlleyCorp | Seed |
| Character Capital | Series A |
| Amino Collective | Series A |
| Lux Capital | Series A, Seed |
| Obvious Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 8, 2025
$21M grant received
- Dec 1, 2025
Developing AI-powered drug toxicity models for improved safety assessment.
Inductive Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Inductive Bio's valuation, stock price, and market status.
